ANATOMIC STAGE IIB BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IIB BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IIB BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IIB BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for aggressive breast cancer falls short in early trial
Disease control TerminatedThis study tested a two-drug combination (nab-paclitaxel and alpelisib) given before surgery to people with a hard-to-treat type of breast cancer called triple-negative breast cancer that also had specific genetic changes (PIK3CA or PTEN). The goal was to see if the drugs could s…
Matched conditions: ANATOMIC STAGE IIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: ANATOMIC STAGE IIB BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 03:23 UTC